Shortly after that, Mohammad et al. also confirmed the overexpression of ANXA2 in HCC compared to non-tumorous liver tissues, while additionally demonstrating that, in HCC, ANXA2 is tyrosine-phosphorylated and overexpressed at both the transcriptional and translational levels [91]. Here, ANXA2 is linked to hepatocellular carcinoma.